MedDataX Logo

Development of Method of Fructose Identification in Urine to Detect the Viral Infection

NCT ID: NCT01638312

Last Updated: 2015-10-05

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage. There will be 20 samples from the HIV-infected patients and 30 samples from the heath controls. The study will collect 10ml urine and examined fructose and fructose-diphosphate using the polarographic method.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Detection of Drug-Resistant HIV-1 in Taiwan

NCT00690001

HIV Infections
UNKNOWN

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections

NCT00000858

HIV Infections
COMPLETED

Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay

NCT00686205

Healthy Donors HIV Positive
COMPLETED PHASE3

Measurement for Viral Reservoir and Immune Function in HIV-1-infected Patients Under Antiretroviral Therapy

NCT04068441

HIV-1-infection
COMPLETED

Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression

NCT01613157

Human Immunodeficiency Virus
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this research is the attempt to implement a new research method based on modern electrochemistry successes, in particular the development of the polarographic method of fructose and fructose diphosphate identification and its implementation to detect the viral infection in early stage.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Immunodeficiency Virus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HIV infection patient and health people

The study does not have intervention

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HIV infection

Exclusion Criteria

* who are in highly active antiretroviral therapy(HARRT) therapy
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

JihJin Tsai, MD

Role: PRINCIPAL_INVESTIGATOR

The Medicines Company

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung, Taiwan, Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KMUH-IRB-20110188

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection
NCT01065207 COMPLETED NA
Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid
NCT00636220 COMPLETED
Analysis of HIV-1 Replication During Antiretroviral Therapy
NCT00767312 ENROLLING_BY_INVITATION
Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials
NCT00183287 COMPLETED
Acute HIV Infection Observational Study
NCT00296660 COMPLETED
Quantification of Antisense HIV RNA in Patients
NCT05381844 COMPLETED
Analysis of the Reservoir in Individuals Controlling HIV Infection
NCT06016114 NOT_YET_RECRUITING
Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis
NCT07146529 NOT_YET_RECRUITING
Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
NCT01697540 COMPLETED
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
NCT00433628 COMPLETED
HIV-DNA Dynamics in HIV Monoinfected or HIV/HCV Coinfected Patients
NCT02836782 UNKNOWN
Utilizing Computed Tomographic Angiography to Evaluate Coronary Artery Disease in Patients on Long-Term Antiretroviral Therapy
NCT02191306 COMPLETED
Examining Factors That May Influence Resistance to HIV-1 Infection
NCT00351442 COMPLETED
Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais
NCT00713752 COMPLETED
Evaluating Immune Function Tests in People With HIV
NCT00067795 COMPLETED
Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients
NCT02256579 UNKNOWN
The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism
NCT00259727 COMPLETED
The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)
NCT05983536 UNKNOWN
Resistance in HIV+ in North and South
NCT02507921 UNKNOWN
Immunologic Control of Drug Resistant HIV
NCT00053404 UNKNOWN
Understanding HIV Susceptibility in the Female Genital Tract
NCT03064425 COMPLETED
Functional Cure Study of HIV-infected Patients
NCT02794545 COMPLETED NA
Missed Opportunities for HIV Screening in General Practice
NCT07303114 RECRUITING
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
NCT00789009 RECRUITING
Liver Steatosis and Stiffness in HIV
NCT03599882 UNKNOWN